Q Angels

Q Angels is an angel network or syndicate vehicle, signaled by its LinkedIn, Twitter and Crunchbase presence but absence of a dedicated website. Networks of this type typically aggregate angel capital through SPVs or member co-investment structures, often with thesis specialization, regional focus or alumni-network roots. The source data carries no disclosed healthcare thesis, sub-vertical focus, AI angle, stage preference, geography or check size. For healthcare founders, Q Angels is most relevant if you are at the seed or pre-seed stage with space in your round for a syndicate-style participatory check, and if the network’s actual thesis aligns with your business after explicit verification. Plausible aggregate check sizes for a syndicate of this profile sit in the $50K to $500K range as a participant alongside lead investors, with the differentiated value being member network access and small-check participation rather than capital scale. The network is a poor fit as a lead investor in any meaningful round, and founders running competitive Series A or B processes should treat it as a syndicate participant rather than a primary investor target. Capital-intensive therapeutics, devices and diagnostics are unlikely strong fits. Entry is best via direct LinkedIn or Twitter outreach to network leadership, supplemented by warm introductions from current member angels. In a first conversation, founders should clarify network size, member commitment dynamics, decision-making process, post-investment engagement model, and concrete healthcare exposure to date before investing significant pitching cycles.